The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats

Journal of Experimental Medicine

Volumn 180, Issue 6, 1994, Pages 2359-2364

  Tautog, Joel D ^a   Richardson, James A ^a   Croft, Joanne T ^c   Simmons, William A ^a,b   Zhou, Ming ^a,b   Luis Fernáindez Sueiro, José ^a   Balish, Edward ^c   Hammerll, Robert E ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B27 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN RECOGNITION; ARTHRITIS; ARTICLE; CONTROLLED STUDY; ENTERITIS; FEMALE; IMMUNOHISTOLOGY; IMMUNOPATHOGENESIS; INTESTINE FLORA; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN INFLAMMATION; TRANSGENIC ANIMAL; UROGENITAL TRACT INFLAMMATION;

ANIMAL; ANIMALS, GENETICALLY MODIFIED; BETA 2-MICROGLOBULIN; BLOTTING, NORTHERN; COLON; COMPARATIVE STUDY; GERM-FREE LIFE; HLA-B27 ANTIGEN; HUMAN; INFLAMMATION; INTESTINAL DISEASES; JOINT DISEASES; LIVER; MALE; OROSOMUCOID; RATS; RATS, INBRED F344; RATS, INBRED LEW; RNA, MESSENGER; SKIN; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028003794     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.180.6.2359     Document Type: Article

References (24)

1. Amett, F.C. 1984. HLA and the spondylarthropathies. In Spon- dylarthropathies. A. Calin, editor. Grime & Stratton, Inc. Orland o, FL. 297-321.
2. Flammer, R.E., S.D. Maika, J.A. Richardson, J.-P. Tang, and J. D. Taurog. 1990. Spontaneous inflammatory disease in trans genic rats expressing HLA-B27 and human β2-m: an animal model of FILA-B27-associated human disorders. Cell. 63:1099.
3. Keat, A. 1983. Reiter’s syndrome and reactive arthritis in per spective. N. Engl. J. Med. 309:1606.
4. Dekker-Saeys, B.J., S.G. Meuwissen, E.M. Van Den Berg Loonen, W.H. De Haas, D. Agenant, and G.N. Tytgat. 1978. Ankylosing spondylitis and inflammatory bowel disease. II. Prevalence of peripheral arthritis, sacroiliitis, and ankylosing spondylitis in patients suffering from inflammatory bowel dis ease. Ann. Rheum. Dis. 37:33.
5. Yang, H., T. Shohat, and J.I. Rotter. 1992. The genetics of inflammatory bowel disease. In Inflammatory Bowel Disease. R.P. MacDermott and W.F. Stenson, editors. Elsevier Science Publishing Co., Inc., New York. 17-51.
6. Woodrow, J.C. 1985. Genetic aspects of the spondyloarthropa thies. Clin. Rheum. Dis. 11:1.
7. Mielants, H., E.M. Veys, C. Cuvelier, and M. De Vos. 1989. Subclinical involvement of the gut in undifferentiated spon dylarthropathies. Clinical and Experimental Rheumatology. 7:499.
8. Mielants, H., E.M. Veys, S. Goemaere, C. Cuvelier, and M. De Vos. 1993. A prospective study of patients with spon dyloarthropathy with special reference to HLA-B27 and to gut histology. J. Rheumatol. 20:1353.
9. Leirisalo-Repo, M., U. Turunen, S. Stenman, P. Helenius, and K. Seppala. 1994. High frequency of silent inflammatory bowel disease in spondyloarthropathy. Arthritis Rheum. 37:23.
10. Raybourne, R.B., and K.M. Williams. 1990. Monoclonal an tibodies against an HLA-B27-derived peptide react with an epitope present on bacterial proteins. J. Immunol. 145:2539.
11. Scofield, R.H., W.L. Warren, G. Koelsch, and J.B. Harley. 1993. A hypothesis for the HLA-B27 immune dysregulation in spondyloarthropathy: contributions from enteric organisms, B27 structure, peptides bound by B27, and convergent evolu tion. Proc. Natl. Acad. Sci. USA. 90:9330.
12. Kapasi, K., and R.D. Inman. 1992. HLA-B27 expression modu lates gram-negative bacterial invasion into transfected L cells. J. Immunol. 148:3554.
13. Stimpson, S.A., R.R. Brown, S.K. Anderle, D.G. Klapper, R.L. Clark, W.J. Cromartie, and J.H. Schwab. 1986. Ar- thropathic properties of cell wall polymers from normal flora bacteria. Infect. Immun. 51:240.
14. Taurog, J.D., S.D. Maika, W.A. Simmons, M. Breban, and R.E. Hammer. 1993. Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expression. J. Immunol. 150:4168.
15. Breban, M., R.E. Hammer, J.A. Richardson, and J.D. Taurog. 1993. Transfer of the inflammatory disease of HL α-B27 trans genic rats by bone marrow engraftment.J. Exp Med. 178:1606.
16. Baumann, H., and L.E. Maquat. 1986. Localization of DNA sequences involved in dexamethasone-dependent expression of the rat al-acid glycoprotein gene. Mol. Cell. Biol. 6:2551.
17. Schaedler, R.W., R. Dubos, and R. Costello. 1965. Associa tion of germffee mice with bacteria isolated from normal mice. J. Exp Med. 122:77.
18. Thompson, G.R., and P.C. Trexler. 1971. Gastrointestinal struc ture and function in germ-free or gnotobiotic animals. Gut 12:230.
19. Turnley, A.M., G. Morahan, H. Okano, O. Bernard, K. Mikoshiba, J. Allison, P.F. Bartlett, and J.F.A.P. Miller. 1991. Dysmyelination in transgenic mice resulting from expression of class I histocompatibility molecules in oligodendrocytes. Na ture (Lond.). 353:566.
20. Yoshioka, T., L. Feigenbaum, and G. Jay. 1991. Transgenic mouse model for central nervous system demyelination. Mol. Cell. Biol. 11:5479.
21. Chadwick, V.S., and R.P. And erson. 1992. Microorganisms and their products in inflammatory bowel disease. In Inflam matory Bowel Disease. R.P. MacDermott and W.F. Stenson, editors. Elsevier Science Publishers Co., Inc., New York. 241-258.
22. Sadlack, B., H. Merz, H. Schorle, A. Schimpl, A.C. Feller, and I. Horak. 1993. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell. 75:253.
23. Schumacher, H.R., Jr. 1984. Enteropathic arthropathies. In Spondylarthropathies. A. Calin, editor. Gruñe & Stratton, Inc. Orland o, FL. 209-240.
24. Kirwan, J., A. Edwards, B. Huitfeldt, P. Thompson, and H. Currey. 1993. The course of established ankylosing spondy litis and the effects of sulphasalazine over 3 years. Brit.J. Rheu matol. 32:729